medigraphic.com
SPANISH

Revista Médica del Hospital General de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2001, Number S1

<< Back Next >>

Rev Med Hosp Gen Mex 2001; 64 (S1)

Future indications for COX-2 selective inhibitors

Cardiel MH
Full text How to cite this article

Language: Spanish
References: 14
Page: 46-48
PDF size: 59.64 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Blain H, Jouzeau JY, Blain A, Terlain B, Trechot P, Touchon J, Netter P, Jeandel C. Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer´s disease. Presse Med 2000; 12; 29(5): 267-73.

  2. Broe GA, Grayson DA, Creasey HM, Waite LM, Casey BJ, Bennett HP, Brooks WS, Halliday GM. Anti-inflammatory drugs protect against Alzheimer disease at low doses. Arch Neurol 2000; 57(11): 1586-91.

  3. Halliday GM, Shepherd CE, McCann H, Reid WG, Grayson DA, Broe GA, Kril JJ. Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease. Arch Neurol 2000; 57(6):831-6.

  4. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K. Antiangiogenic and antitumor activities of cyclooxygenase– 2 Inhibitors. Cancer Res 2000; 60(5): 1306-11.

  5. Reddy BS, Rao CV. Colon cancer; a role for cyclo-oxygenase- 2-specific nonsteroidal anti-inflammatory drugs. Drugs Aging 2000; 16(5): 329-34.

  6. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997; 89: 1406-22.

  7. Jane PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med 2000; 342(36): 1960-68.

  8. Fosslien E. Biochemistry of cyclooxygenase (COX)-2 Inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 2000; 37(5): 431-502.

  9. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su Lk, Levin B. The effect of celecoxib, a cyclooxygenase- 2 Inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342(26): 1946-52.

  10. Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, Kellogg GJ, Hill DL, Seibert K. Celecoxib inhibits n-butyl-N-(4-Hydroxybuty1)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer- 344 rats. Cancer Res 2000; (20): 5599-602.

  11. Wilgus TA, Ross MS, Parrett ML, Obersyszyn TM. Topical application of a selective cyclooxygenase inhibitor suppress uvb mediated cutaneous inflammation. Prostaglandins other lipid mediat 2000; 62(4): 367-84.

  12. Dahlen B. Celecoxib in patients with asthma and aspirin intolerance. NEJM 2001; 344(2): 142-44.

  13. Gross G, Imamura T, Vogt SK, Wozniak DF, Nelson DM, Sadovsky Y, Muglia LJ. Inhibition of cyclooxygenase-2 Prevents inflammation-mediated preterm labor in the mouse. Am J Phsiol Regul Integr Comp Physiol 2000; 278(6): R1415-23.

  14. Chen N, Warnen JL, Reiss CS. NSAID treatment suppresses VSV Propagation in mouse CNS. Virology 2000; 276(1): 44-51.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Hosp Gen Mex. 2001;64